Pharma Pulse 2/19/25: Pharma in the Age of Social Media, Rising Demand for GLP-1 Receptor Agonists Means More Questions & more

Navigating Distrust: Pharma in the Age of Social Media

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Rising Demand for GLP-1 Receptor Agonists Means an Increase in Patient Questions

Pharmacists should emphasize the importance of medication adherence and lifestyle changes.

New York State Bans DeepSeek From Government Devices

New York state banned the use of DeepSeek on government devices, citing concerns over data privacy and censorship in the popular generative artificial intelligence app from China.

DeepSeek, owned by Chinese hedge fund High-Flyer, shot to fame in January, with its low-cost AI models rivaling American ones using less-advanced Nvidia chips.

Bayer^® Aspirin Continues Longstanding Commitment to Heart Health Education, Encouraging Americans to “See Their Risks”

In the United States alone, 104 million people are at risk of cardiovascular disease, and in a study of those that experienced a heart attack at age 50 or younger, half were not previously seen as high risk. This February, Bayer^® Aspirin is marking Heart Health Month with a new initiative to raise awareness and education about cardiovascular risk factors — especially among those who may dismiss the connection between age and heart health — and empower people to take proactive steps toward protecting their heart health by speaking with their healthcare provider about their risk factors.

ApprovalFlow on LinkedIn

Regulatory evolution is key as AI transforms pharmaceutical development.
At ApprovalFlow, we see firsthand how streamlined approvals help pharma teams stay agile and compliant in this shifting landscape.
Looking forward to these insights!
#RegulatoryInnovation #PharmaDevelopment #AIinPharma

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs